Home » Cepheid Receives FDA Clearance for Test for HAI-Associated Gene
Cepheid Receives FDA Clearance for Test for HAI-Associated Gene
Cepheid Wednesday announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert vanA, the first rapid and accurate
test released in the United States for vanA, the antimicrobial resistance gene most commonly associated with vancomycin-resistant enterococci — one
of the more serious healthcare-associated infections (HAI).
Fox Business
Fox Business
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May